Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Active DNA demethylation is required for photoreceptors fate specification and function

Ismael Hernandez-Nunez; Alaina Urman; Xiaodong Zhang; William Jacob; Qiang Li; Fengbiao Mao; Andi Cani; Shiming Chen; Meelad Dawlaty; Rajesh Rao; Philip Ruzycki; John Edwards; Brian Clark

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):472.

ARVO Annual Meeting Abstract June 2025

Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Implantation in Patients with Dry Age-related Macular Degeneration (AMD): Early Low Dose Clinical Outcomes

Jeffrey Stern; Rajesh Rao; Brigitte Arduini; Shuna Park; Glenna Ford; Paul P Lee; Susan Borden; Charles William Ryan; Dhruv Sareen; Clive Svendsen; Keith Wolsieffer; Sally Temple

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2701.

ARVO Annual Meeting Abstract June 2024

Trends of Vitreoretinal Surgical Referrals from 2012 - 2022

Jonah E Yousif; Huiyan Jin; David Samuel Portney; Warren Wang Pan; Rajesh Rao

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2158.

ARVO Annual Meeting Abstract June 2024

Liquid biopsy for proliferative diabetic retinopathy: single-cell transcriptomics (scRNA-seq) of human vitreous reveals inflammatory T cell signature

Rachana Haliyur; David Parkinson; Jing Xu; Qiang Li; Yuanhao Huang; Jie Liu; Feiyang Ma; Johann Gudjonsson; Rajesh Rao

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):935.

ARVO Annual Meeting Abstract June 2024

HESX1 Regulates Formation of the Early Retinal Neuroectoderm: a 3D Organoid Study

Tyler Jordan Carman; Makena Crimaldi; Qiang Li; Rajesh Rao

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6704.

ARVO Annual Meeting Abstract June 2024

Opportunity Costs of Vitreoretinal Surgical Referrals at a Tertiary Care Center

Charles William Ryan; Jonah E Yousif; Rajesh Rao

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6418.

ARVO Annual Meeting Abstract June 2023

Cost drivers of pars plana vitrectomy (PPV) for retinal detachment: a time-driven activity-based costing analysis

David Samuel Portney; Warren Wang Pan; Shahzad Mian; Rajesh C Rao

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4552.

ARVO Annual Meeting Abstract June 2023

Regulation of Retinal Development by PRDM13, a Protein Implicated in North Carolina Macular Dystrophy

Brian Basinski; qiang li; Jing Xu; Tyler Carman; yuanhao huang; Rajesh C Rao

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4452.

ARVO Annual Meeting Abstract June 2022

Synthetic Matrices with Customizable Cell-Matrix Interfaces Enhance Retinal Organoid Culture

Daniel Balikov; Brian Basinski; Ariella Shikanov; Rajesh Rao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1470.

ARVO Annual Meeting Abstract June 2021

Research funding, income, and career satisfaction among clinician-scientists in ophthalmology in the United States

Alexander Rusakevich; Nicholas Protopsaltis; Rajesh C Rao; Daniel L Chao; Glenn Yiu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2646.

Letters to the Editor January 2021

The Clinician-Scientist in Vision Science: A Rare and Endangered Species

PDF

Rajesh C. Rao
TAGS: clinicians, vision
Trans. Vis. Sci. Tech.. 2021; 10(1):30. https://doi.org/10.1167/tvst.10.1.30

Articles November 2020

Sustaining Independent Careers in Vision Research: Demographics and Success in Second R01 Attainment Among Clinician–Scientists from 1985 to 2019

PDF

Elaine A. Liu; Sophia Y. Wang; Rajesh C. Rao

Trans. Vis. Sci. Tech.. 2020; 9(12):32. https://doi.org/10.1167/tvst.9.12.32

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Pentosan Polysulfate Maculopathy: Disease Course after Drug Cessation

Rachel Shah; Riley Lyons; Joseph Simonett; Mark E Pennesi; Rajesh C Rao; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1063.

ARVO Annual Meeting Abstract June 2020

Characterization of 'Early Established' Clinician-Scientist Cohorts in Ophthalmology: Success Rates for 2nd R01 Grant Awards

Rajesh C Rao; Elaine Liu; Sophia Y Wang

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5118.

ARVO Annual Meeting Abstract June 2020

Using Discrete Choice Analysis to Model Patient Decision-Making for Ocular Stem Cell Therapies

Peter Y Zhao; Paula Anne Newman-Casey; Chris A Andrews; Angeline Lonardi; Sunjong Ji; Olivia Bennett; Duyhoang Dinh; Nidhi Talwar; David W Hutton; Rajesh C Rao

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):869.

Review June 2020

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

PDF

Debra A. Thompson; Alessandro Iannaccone; Robin R. Ali; Vadim Y. Arshavsky; Isabelle Audo; James W. B. Bainbridge; Cagri G. Besirli; David G. Birch; Kari E. Branham; Artur V. Cideciyan; Steven P. Daiger; Deniz Dalkara; Jacque L. Duncan; Abigail T. Fahim; John G. Flannery; Roberto Gattegna; John R. Heckenlively; Elise Heon; K. Thiran Jayasundera; Naheed W. Khan; Henry Klassen; Bart P. Leroy; Robert S. Molday; David C. Musch; Mark E. Pennesi; Simon M. Petersen-Jones; Eric A. Pierce; Rajesh C. Rao; Thomas A. Reh; Jose A. Sahel; Dror Sharon; Paul A. Sieving; Enrica Strettoi; Paul Yang; David N. Zacks; The Monaciano Consortium
TAGS: outcome measures, retinal diseases, surrogate endpoints, genetics, vision, natural history, ethics, gene therapy
Trans. Vis. Sci. Tech.. 2020; 9(7):2. https://doi.org/10.1167/tvst.9.7.2

ARVO Annual Meeting Abstract July 2019

The Histone Methyltransferase NSD2 is a New Histopathologic Biomarker and Potential Therapeutic Target for Human Retinoblastoma.

Rajesh C Rao; Zhenhua Zou

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1321.

ARVO Annual Meeting Abstract July 2018

COMPASS acts as a temporal rheostat to control retinal neuroectoderm versus mesoderm fate choice.

Rajesh C Rao; Qiang Li; Fengbao Mao; Yali Dou

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):571.

ARVO Annual Meeting Abstract July 2018

The Role of Midperipheral Retinal Non-perfusion in Diabetic Macular Edema.

Amro Omari; Lydia Su; Christopher Sesi; Katherine Jolitkov; Rajesh C Rao; Anjali Shah; Thiran Jayaundera; Thomas Gardner

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4854.

ARVO Annual Meeting Abstract June 2017

Precision medicine for vitreoretinal lymphomas: new routes to targeted therapies from liquid biopsies

Rajesh C Rao; Andi K. Cani; Daniel H. Hovelson; Hakan Demirci; Mark W Johnson; Scott A Tomlins

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1251.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Active DNA demethylation is required for photoreceptors fate specification and function

Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Implantation in Patients with Dry Age-related Macular Degeneration (AMD): Early Low Dose Clinical Outcomes

Trends of Vitreoretinal Surgical Referrals from 2012 - 2022

Liquid biopsy for proliferative diabetic retinopathy: single-cell transcriptomics (scRNA-seq) of human vitreous reveals inflammatory T cell signature

HESX1 Regulates Formation of the Early Retinal Neuroectoderm: a 3D Organoid Study

Opportunity Costs of Vitreoretinal Surgical Referrals at a Tertiary Care Center

Cost drivers of pars plana vitrectomy (PPV) for retinal detachment: a time-driven activity-based costing analysis

Regulation of Retinal Development by PRDM13, a Protein Implicated in North Carolina Macular Dystrophy

Synthetic Matrices with Customizable Cell-Matrix Interfaces Enhance Retinal Organoid Culture

Research funding, income, and career satisfaction among clinician-scientists in ophthalmology in the United States

The Clinician-Scientist in Vision Science: A Rare and Endangered Species

Sustaining Independent Careers in Vision Research: Demographics and Success in Second R01 Attainment Among Clinician–Scientists from 1985 to 2019

Pentosan Polysulfate Maculopathy: Disease Course after Drug Cessation

Characterization of 'Early Established' Clinician-Scientist Cohorts in Ophthalmology: Success Rates for 2nd R01 Grant Awards

Using Discrete Choice Analysis to Model Patient Decision-Making for Ocular Stem Cell Therapies

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

The Histone Methyltransferase NSD2 is a New Histopathologic Biomarker and Potential Therapeutic Target for Human Retinoblastoma.

COMPASS acts as a temporal rheostat to control retinal neuroectoderm versus mesoderm fate choice.

The Role of Midperipheral Retinal Non-perfusion in Diabetic Macular Edema.

Precision medicine for vitreoretinal lymphomas: new routes to targeted therapies from liquid biopsies

To View More...

You must be signed into an individual account to use this feature.